Migration and invasion assays showed that the overexpression of PRSS22 enhanced migration and invasion compared with the control group, whereas PRSS22 knockdown markedly suppressed the migratory and invasive abilities of BC cells (Fig. 3E–H). The gene discussed is PRSS22; the disease is breast cancer.